Aarti Drugs Limited
Aarti Drugs Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: AARTIDRUGS and BSE: 524348 (ISIN INE767A01016).
It has a market capitalisation of ₹3,644 crore, a last close of ₹399.30 on 2026-10-19, a one-year return of -22.9%.
Valuation: a price-to-earnings ratio of 19.06x, a price-to-book ratio of 2.35x, a dividend yield of 0.5%.
Profitability: return on equity of 13.4%, return on capital employed of 13.5%, an operating margin of 12.4%.
Growth: sales growth of -1.9% a year over three years, net profit growth of 5.4% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.37x, promoter holding of 54.1%.
| Metric | Value |
|---|---|
| Market capitalisation | 3,644 |
| Last close | ₹399.30 |
| P/E (TTM) | 19.06x |
| P/B | 2.35x |
| Dividend yield | 0.5% |
| ROE (FY) | 13.4% |
| ROCE (FY) | 13.5% |
| Operating margin (TTM) | 12.4% |
| Sales growth, 3-year CAGR | -1.9% |
| Profit growth, 3-year CAGR | 5.4% |
| Debt / equity | 0.37x |
| Promoter holding | 54.1% |
| 1-year return | -22.9% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means